Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Papadimitriou K"'
Autor:
Alvarez, E. C., Giallombardo, M., Ignacio Gil-Bazo, Papadimitriou, K., Pauwels, P., Peeters, M., Rolfo, C.
Publikováno v:
Europe PubMed Central
ResearcherID
Minerva chirurgica: rivista quindicinale di chirurgia pratica
ResearcherID
Minerva chirurgica: rivista quindicinale di chirurgia pratica
Advanced hepatocellular carcinoma remains an entity that is hard to approach therapeutically and has shown disappointing results in terms of survival. For many years, the only accepted option for this setting was the use of a multikinase inhibitor, s
Autor:
Jk, Field, Yiagnisis M, Demetrios Spandidos, Jr, Gosney, Papadimitriou K, Ed, Vaughan, Pm, Stell
Publikováno v:
Europe PubMed Central
We have previously demonstrated that the Ha-ras and the Ki-ras oncogenes are overexpressed in squamous cell carcinoma of the head and neck. In this study we have used the Y13-259 monoclonal antibody to p21 ras to determine if expression of the ras on
Publikováno v:
Europe PubMed Central
Anticancer Research 9:6(Nov-Dec1989):1505-1510
Anticancer Research 9:6(Nov-Dec1989):1505-1510
We have employed an immunohistochemical analysis to study the ras p21 oncoprotein in a total of 88 gastric carcinomas, which were associated (in 24 cases) with intestinal metaplasia. Our results suggest an association of the expression of ras p21 wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::0aac07efe76b5c9fa5352f0bc0901bcc
http://europepmc.org/abstract/med/2697179
http://europepmc.org/abstract/med/2697179
Publikováno v:
Europe PubMed Central
Seventy-five squamous cell carcinomas of the head and neck were analysed for c-erbB-2 expression using immunohistochemical techniques with four different c-erbB-2 antibodies. No membrane staining was seen in any of the squamous cell carcinomas studie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::7f452c31ec09d1e79f7db59de439f66e
http://europepmc.org/abstract/med/1377893
http://europepmc.org/abstract/med/1377893
Publikováno v:
Europe PubMed Central
The expression of ras, c-myc and c-erbB-2 oncoproteins in 100 human (73 ductal and 27 lobular) breast carcinomas has been examined using an immunohistochemical analysis. The monoclonal antibody Y13 259 has been used for the ras p21, the monoclonal an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::66adc07e9b3463d97fef484be2cdbf28
http://europepmc.org/abstract/med/2574023
http://europepmc.org/abstract/med/2574023
Publikováno v:
Europe PubMed Central
The monoclonal antibody Y13 259 to the ras oncogene p21 product was used in an immunohistochemical study of ras expression in human thyroid neoplasms. Both papillary and follicular carcinomas showed consistently higher staining intensity than normal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3502ce0f6c4e3cb344d64c39e3c504e8
http://europepmc.org/abstract/med/3064713
http://europepmc.org/abstract/med/3064713
Publikováno v:
Europe PubMed Central
Scopus-Elsevier
Scopus-Elsevier
Ras and c-myc oncoprotein expression was analyzed using specific monoclonal antibodies Y13-259 (for ras p21) and mycl-9E10 (for c-myc p62) in 144 histological sections derived from benign gastric lesions. Increased expression of ras p21 was observed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::00b374ca002c7671cb90181ede891557
http://europepmc.org/abstract/med/2241094
http://europepmc.org/abstract/med/2241094
Autor:
Christian Rolfo, Andreia Coelho, Marc Peeters, Giuseppe Bronte, Francesco Passiglia, Konstantinos Papadimitriou, Kathleen E. De Greef, Antonio Russo, Thiery Chapelle
Publikováno v:
World journal of gastroenterology
Colorectal cancer (CRC) is one of the leading causes of cancer-related death. Surgery, radiotherapy and chemotherapy have been till now the main therapeutic strategies for disease control and improvement of the overall survival. Twenty-five per cent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9a2026e3a9d3c03eada13c2591442a7
https://europepmc.org/articles/PMC4997640/
https://europepmc.org/articles/PMC4997640/
Autor:
Roy Remmen, Christian Rolfo, Konstantinos Papadimitriou, Lúcia Farracho, Ana Dolcan, Francesco Passiglia, Patrick Pauwels, Tereza Ondøichová, Marta Castiglia, Marcin Ostrowski
Publikováno v:
Journal of the American Board of Family Medicine
In the past decade the advent of target therapy has led to a silent revolution in the treatment of lung cancer. Thanks to the specificity of their target, new tailored drugs are able to achieve a larger benefit and lower toxicity and provide better q
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e43b2c9dbf81871f41e74ef72cc5042
http://www.jabfm.org
http://www.jabfm.org
Autor:
Antonio Russo, Konstantinos Papadimitriou, Giovanni Sortino, Eugenio Fiorentino, Christian Rolfo, Francesco Passiglia, Giuseppe Bronte, Ghada Marogy, Marc Peeters
Publikováno v:
Expert review of gastroenterology & hepatology
Many targeted drugs have been studied to target the molecular pathways involved in the development of gastrointestinal cancers. Anti-VEGF, anti-EGFR agents, and recently also multi-kinase inhibitor regorafenib, have already been available for the tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63d649fcb12aa3d1129d54ffbe8e12eb
http://hdl.handle.net/10447/109880
http://hdl.handle.net/10447/109880